North America Non-Invasive Prenatal Testing Market Size is USD 2.06 Billion in 2026

North America Non-Invasive Prenatal Testing Market (By Gestation Period: 0–12 Weeks, 13–24 Weeks, and 25–36 Weeks; By Pregnancy Risk: High and Average Risk and Low Risk; By Method: Cell-free DNA in Maternal Plasma Tests, Biochemical Screening, and Ultrasound Detection; By Technology: NGS, PCR, Array Technology, and Others; By Product: Consumables & Reagents and Instruments; By Application: Trisomy, Microdeletion Syndrome, and Other Applications; By End Use: Hospitals & Clinics and Diagnostic Laboratories) Industry Size, Share, Growth, Trends 2025-2035

Report Code : 1508 | Published : 04 Jun 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 1.88 Bn

Forecast Year,

USD 4.62 Bn

CAGR, 2026 - 2035

9.40%

Report Coverage

North America

Download Databook

The North America non-invasive prenatal testing market size surpassed USD 1.88 billion in 2025 and is predicted to reach around USD 4.62 billion by 2035, registering a CAGR of 9.4% from 2026 to 2035.The market is observed to grow rapidly due to higher demand for non-invasive and safe options.

North America Non-Invasive Prenatal Testing Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 1.88 Billion
Market Size in 2026	USD 2.06 Billion
Market Size by 2035	USD 4.62 Billion
CAGR 2026 to 2035	9.4%
Base Year	2025
Forecast Period	2026 to 2035

The North America non-invasive prenatal testing market has been growing in recent years due to major factors such as increasing maternal age and a major shift to non-invasive and safe techniques.

North America Non-Invasive Prenatal Testing Market, By Gestation Period, 2025 (%)

Segments	Shares (%)
0–12 Weeks	54%
13–24 Weeks	32%
25–36 Weeks	14%

0-12 Weeks - The dominating segment accounts 54% of the market share and is expected to grow due to higher demand for early detection and safe decision-making in the early stages.
13-24 Weeks - The segment accounts for 32% of the market share and is driven by the importance of mid-trimester prenatal screening for fetal assessment and confirmation.

North America Non-Invasive Prenatal Testing Market, By Pregnancy Risk, 2025 (%)

Segments	Shares (%)
High and Average Risk	68%
Low Risk	32%

High and Average Risk - The dominating segment accounts 68% of the market share due to strong clinical recommendations and high-testing adoptions in risk-prone cases.
Low Risk - The segment holds 32% of the market share and is driven by the importance of screening to ensure a safe pregnancy with no prior risk indicators.

North America Non-Invasive Prenatal Testing Market, By Method, 2025 (%)

Segments	Shares (%)
Cell-free DNA in Maternal Plasma Tests	50%
Biochemical Screening	28%
Ultrasound Detection	22%

Ultrasound Detection - The segment holds 22% of the market share as it is an image-based screening method useful for structural fetal assessment.
Biochemical Screening - The segment accounts for 28% of the market share, and it involves blood-based tests analysing biomarkers to detect genetic abnormalities.

North America Non-Invasive Prenatal Testing Market, By Technology, 2025 (%)

Segments	Shares (%)
NGS	52%
PCR	20%
Array Technology	18%
Others	10%

NGS - The dominating segment accounts 52% of the market share and is driven by its superior accuracy and higher usage for advanced prenatal testing.
Array Technology - The segment holds 18% of the market share as it is a genomic analysis method to detect chromosomal variations.

North America Non-Invasive Prenatal Testing Market, By Product, 2025 (%)

Segments	Shares (%)
Consumables and Reagents	66%
Instruments	34%

Consumables and Reagents - The dominating segment accounts for 66% of the market share due to their higher demand in testing procedures.
Instruments - The segment signifies 34% of the market share, as they are used for conducting prenatal testing.

North America Non-Invasive Prenatal Testing Market, By Application, 2025 (%)

Segments	Shares (%)
Trisomy	58%
Microdeletion Syndrome	22%
Other Applications	20%

Trisomy - The dominating segment accounts 58% of the market share due to its high prevalence and strong clinical screening demand.
Microdeletion Syndrome - The segment accounts for 22% of market share as it involves testing for small chromosomal deletions affecting fetal development.

North America Non-Invasive Prenatal Testing Market, By End Use, 2025 (%)

Segments	Shares (%)
Hospitals and Clinics	61%
Diagnostic Laboratories	39%

Hospitals and Clinics - The dominating segment holds 61% of the market share, mainly due to high patient inflow.
Diagnostic Laboratories - The segment has a notable share of 39% and, as it provides specialized facilities for advanced genetic and prenatal tests.

Top Companies in the North America Non-Invasive Prenatal Testing Market

Genesis Genetics (CooperSurgical, Inc.)
Natera, Inc.
Eurofins LifeCodexx GmbH
Illumina, Inc. (Verinata Health, Inc.)
Centogene N.V.
MedGenome Labs Ltd.
Myriad Women's Health, Inc. (Counsyl, Inc.)
F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
Qiagen
Laboratory Corp. of America Holdings
Progenity, Inc.
Quest Diagnostics, Inc.

Segments Covered in the Report

By Gestation Period

0–12 Weeks
13–24 Weeks
25–36 Weeks

By Pregnancy Risk

High and Average Risk
Low Risk

By Method

Cell-free DNA in Maternal Plasma Tests
Biochemical Screening
Ultrasound Detection

By Technology

NGS
PCR
Array Technology
Others

By Product

Consumables and Reagents
Instruments

By Application

Trisomy
Microdeletion Syndrome
Other Applications

By End Use

Hospitals and Clinics
Diagnostic Laboratories

List of Tables & Figures

List of Tables

Table 1: North America Non-Invasive Prenatal Testing Market Size, by Gestation Period, 2025-2035 (USD Billion)
Table 2: North America Non-Invasive Prenatal Testing Market Size, by Pregnancy Risk, 2025-2035 (USD Billion)
Table 3: North America Non-Invasive Prenatal Testing Market Size, by Method, 2025-2035 (USD Billion)
Table 4: North America Non-Invasive Prenatal Testing Market Size, by Technology, 2025-2035 (USD Billion)
Table 5: North America Non-Invasive Prenatal Testing Market Size, by Product, 2025-2035 (USD Billion)
Table 6: North America Non-Invasive Prenatal Testing Market Size, by Application, 2025-2035 (USD Billion)
Table 7: North America Non-Invasive Prenatal Testing Market Size, by End Use, 2025-2035 (USD Billion)
Table 8: North America Non-Invasive Prenatal Testing Market Size, by 0–12 Weeks, 2025-2035 (USD Billion)
Table 9: North America Non-Invasive Prenatal Testing Market Size, by 13–24 Weeks, 2025-2035 (USD Billion)
Table 10: North America Non-Invasive Prenatal Testing Market Size, by 25–36 Weeks, 2025-2035 (USD Billion)
Table 11: North America Non-Invasive Prenatal Testing Market Size, by High and Average Risk, 2025-2035 (USD Billion)
Table 12: North America Non-Invasive Prenatal Testing Market Size, by Low Risk, 2025-2035 (USD Billion)
Table 13: North America Non-Invasive Prenatal Testing Market Size, by Cell-free DNA in Maternal Plasma Tests, 2025-2035 (USD Billion)
Table 14: North America Non-Invasive Prenatal Testing Market Size, by Biochemical Screening, 2025-2035 (USD Billion)
Table 15: North America Non-Invasive Prenatal Testing Market Size, by Ultrasound Detection, 2025-2035 (USD Billion)
Table 16: North America Non-Invasive Prenatal Testing Market Size, by NGS, 2025-2035 (USD Billion)
Table 17: North America Non-Invasive Prenatal Testing Market Size, by PCR, 2025-2035 (USD Billion)
Table 18: North America Non-Invasive Prenatal Testing Market Size, by Array Technology, 2025-2035 (USD Billion)
Table 19: North America Non-Invasive Prenatal Testing Market Size, by Others (Technology), 2025-2035 (USD Billion)
Table 20: North America Non-Invasive Prenatal Testing Market Size, by Consumables and Reagents, 2025-2035 (USD Billion)
Table 21: North America Non-Invasive Prenatal Testing Market Size, by Instruments, 2025-2035 (USD Billion)
Table 22: North America Non-Invasive Prenatal Testing Market Size, by Trisomy, 2025-2035 (USD Billion)
Table 23: North America Non-Invasive Prenatal Testing Market Size, by Microdeletion Syndrome, 2025-2035 (USD Billion)
Table 24: North America Non-Invasive Prenatal Testing Market Size, by Other Applications, 2025-2035 (USD Billion)
Table 25: North America Non-Invasive Prenatal Testing Market Size, by Hospitals and Clinics, 2025-2035 (USD Billion)
Table 26: North America Non-Invasive Prenatal Testing Market Size, by Diagnostic Laboratories, 2025-2035 (USD Billion)

List of Figures

Figure 1: North America Non-Invasive Prenatal Testing Market Share, by Gestation Period, 2025 (%)
Figure 2: North America Non-Invasive Prenatal Testing Market Share, by Pregnancy Risk, 2025 (%)
Figure 3: North America Non-Invasive Prenatal Testing Market Share, by Method, 2025 (%)
Figure 4: North America Non-Invasive Prenatal Testing Market Share, by Technology, 2025 (%)
Figure 5: North America Non-Invasive Prenatal Testing Market Share, by Product, 2025 (%)
Figure 6: North America Non-Invasive Prenatal Testing Market Share, by Application, 2025 (%)
Figure 7: North America Non-Invasive Prenatal Testing Market Share, by End Use, 2025 (%)
Figure 8: North America Non-Invasive Prenatal Testing Market Forecast, 2025-2035 (USD Billion)
Figure 9: 0–12 Weeks Segment Market Forecast, 2025-2035 (USD Billion)
Figure 10: 13–24 Weeks Segment Market Forecast, 2025-2035 (USD Billion)
Figure 11: 25–36 Weeks Segment Market Forecast, 2025-2035 (USD Billion)
Figure 12: High and Average Risk Segment Market Forecast, 2025-2035 (USD Billion)
Figure 13: Low Risk Segment Market Forecast, 2025-2035 (USD Billion)
Figure 14: Cell-free DNA in Maternal Plasma Tests Segment Market Forecast, 2025-2035 (USD Billion)
Figure 15: Biochemical Screening Segment Market Forecast, 2025-2035 (USD Billion)
Figure 16: Ultrasound Detection Segment Market Forecast, 2025-2035 (USD Billion)
Figure 17: NGS Segment Market Forecast, 2025-2035 (USD Billion)
Figure 18: PCR Segment Market Forecast, 2025-2035 (USD Billion)
Figure 19: Array Technology Segment Market Forecast, 2025-2035 (USD Billion)
Figure 20: Others (Technology) Segment Market Forecast, 2025-2035 (USD Billion)
Figure 21: Consumables and Reagents Segment Market Forecast, 2025-2035 (USD Billion)
Figure 22: Instruments Segment Market Forecast, 2025-2035 (USD Billion)
Figure 23: Trisomy Segment Market Forecast, 2025-2035 (USD Billion)
Figure 24: Microdeletion Syndrome Segment Market Forecast, 2025-2035 (USD Billion)
Figure 25: Other Applications Segment Market Forecast, 2025-2035 (USD Billion)
Figure 26: Hospitals and Clinics Segment Market Forecast, 2025-2035 (USD Billion)
Figure 27: Diagnostic Laboratories Segment Market Forecast, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026